世界の痙性斜頸治療市場規模・現状・予測2021-2027

【英語タイトル】Global Cervical Dystonia Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1251)・商品コード:QY21APR1251
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、痙性斜頸治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ボツリヌス毒素、薬物、その他)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・痙性斜頸治療の市場動向
・企業の競争状況、市場シェア
・痙性斜頸治療の種類別市場規模(ボツリヌス毒素、薬物、その他)
・痙性斜頸治療の用途別市場規模(病院、クリニック、その他)
・痙性斜頸治療の北米市場規模2016-2027(アメリカ、カナダ)
・痙性斜頸治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・痙性斜頸治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・痙性斜頸治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・痙性斜頸治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Allergan、Eisai、Ipsen Pharma、Merz Pharma、US WorldMeds)
・結論
【レポートの概要】

Cervical dystonia (or spasmodic torticollis) is the most common form of focal or localized dystonia. Neurological in origin, it is characterized by muscular spasms that cause abnormal movements of the neck, head and sometimes the shoulders. The neck muscles may contract, twist, tremble, or remain blocked in one direction, resulting in an awkward and uncomfortable posture.

Market Analysis and Insights: Global Cervical Dystonia Therapeutics Market
The global Cervical Dystonia Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cervical Dystonia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cervical Dystonia Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cervical Dystonia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cervical Dystonia Therapeutics market.

Global Cervical Dystonia Therapeutics Scope and Market Size
Cervical Dystonia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cervical Dystonia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Botulinum Toxins
Drug
Other

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan
Eisai
Ipsen Pharma
Merz Pharma
US WorldMeds

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cervical Dystonia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Botulinum Toxins
1.2.3 Drug
1.2.4 Other
1.3 Market by Application
1.3.1 Global Cervical Dystonia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Cervical Dystonia Therapeutics Market Perspective (2016-2027)
2.2 Cervical Dystonia Therapeutics Growth Trends by Regions
2.2.1 Cervical Dystonia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cervical Dystonia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Cervical Dystonia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Cervical Dystonia Therapeutics Industry Dynamic
2.3.1 Cervical Dystonia Therapeutics Market Trends
2.3.2 Cervical Dystonia Therapeutics Market Drivers
2.3.3 Cervical Dystonia Therapeutics Market Challenges
2.3.4 Cervical Dystonia Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Cervical Dystonia Therapeutics Players by Revenue
3.1.1 Global Top Cervical Dystonia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Cervical Dystonia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Cervical Dystonia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cervical Dystonia Therapeutics Revenue
3.4 Global Cervical Dystonia Therapeutics Market Concentration Ratio
3.4.1 Global Cervical Dystonia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cervical Dystonia Therapeutics Revenue in 2020
3.5 Cervical Dystonia Therapeutics Key Players Head office and Area Served
3.6 Key Players Cervical Dystonia Therapeutics Product Solution and Service
3.7 Date of Enter into Cervical Dystonia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Cervical Dystonia Therapeutics Breakdown Data by Type
4.1 Global Cervical Dystonia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Cervical Dystonia Therapeutics Forecasted Market Size by Type (2022-2027)

5 Cervical Dystonia Therapeutics Breakdown Data by Application
5.1 Global Cervical Dystonia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Cervical Dystonia Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Cervical Dystonia Therapeutics Market Size (2016-2027)
6.2 North America Cervical Dystonia Therapeutics Market Size by Type
6.2.1 North America Cervical Dystonia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Cervical Dystonia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Cervical Dystonia Therapeutics Market Size by Type (2016-2027)
6.3 North America Cervical Dystonia Therapeutics Market Size by Application
6.3.1 North America Cervical Dystonia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Cervical Dystonia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Cervical Dystonia Therapeutics Market Size by Application (2016-2027)
6.4 North America Cervical Dystonia Therapeutics Market Size by Country
6.4.1 North America Cervical Dystonia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Cervical Dystonia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Cervical Dystonia Therapeutics Market Size (2016-2027)
7.2 Europe Cervical Dystonia Therapeutics Market Size by Type
7.2.1 Europe Cervical Dystonia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Cervical Dystonia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Cervical Dystonia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Cervical Dystonia Therapeutics Market Size by Application
7.3.1 Europe Cervical Dystonia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Cervical Dystonia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Cervical Dystonia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Cervical Dystonia Therapeutics Market Size by Country
7.4.1 Europe Cervical Dystonia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Cervical Dystonia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Cervical Dystonia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cervical Dystonia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Cervical Dystonia Therapeutics Market Size (2016-2027)
9.2 Latin America Cervical Dystonia Therapeutics Market Size by Type
9.2.1 Latin America Cervical Dystonia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Cervical Dystonia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Cervical Dystonia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Cervical Dystonia Therapeutics Market Size by Application
9.3.1 Latin America Cervical Dystonia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Cervical Dystonia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Cervical Dystonia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Cervical Dystonia Therapeutics Market Size by Country
9.4.1 Latin America Cervical Dystonia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Cervical Dystonia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Cervical Dystonia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cervical Dystonia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Cervical Dystonia Therapeutics Introduction
11.1.4 Allergan Revenue in Cervical Dystonia Therapeutics Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Cervical Dystonia Therapeutics Introduction
11.2.4 Eisai Revenue in Cervical Dystonia Therapeutics Business (2016-2021)
11.2.5 Eisai Recent Development
11.3 Ipsen Pharma
11.3.1 Ipsen Pharma Company Details
11.3.2 Ipsen Pharma Business Overview
11.3.3 Ipsen Pharma Cervical Dystonia Therapeutics Introduction
11.3.4 Ipsen Pharma Revenue in Cervical Dystonia Therapeutics Business (2016-2021)
11.3.5 Ipsen Pharma Recent Development
11.4 Merz Pharma
11.4.1 Merz Pharma Company Details
11.4.2 Merz Pharma Business Overview
11.4.3 Merz Pharma Cervical Dystonia Therapeutics Introduction
11.4.4 Merz Pharma Revenue in Cervical Dystonia Therapeutics Business (2016-2021)
11.4.5 Merz Pharma Recent Development
11.5 US WorldMeds
11.5.1 US WorldMeds Company Details
11.5.2 US WorldMeds Business Overview
11.5.3 US WorldMeds Cervical Dystonia Therapeutics Introduction
11.5.4 US WorldMeds Revenue in Cervical Dystonia Therapeutics Business (2016-2021)
11.5.5 US WorldMeds Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Cervical Dystonia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Botulinum Toxins
Table 3. Key Players of Drug
Table 4. Key Players of Other
Table 5. Global Cervical Dystonia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Cervical Dystonia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cervical Dystonia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Cervical Dystonia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Cervical Dystonia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Cervical Dystonia Therapeutics Market Share by Regions (2022-2027)
Table 11. Cervical Dystonia Therapeutics Market Trends
Table 12. Cervical Dystonia Therapeutics Market Drivers
Table 13. Cervical Dystonia Therapeutics Market Challenges
Table 14. Cervical Dystonia Therapeutics Market Restraints
Table 15. Global Cervical Dystonia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Cervical Dystonia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Cervical Dystonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Dystonia Therapeutics as of 2020)
Table 18. Ranking of Global Top Cervical Dystonia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Cervical Dystonia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cervical Dystonia Therapeutics Product Solution and Service
Table 22. Date of Enter into Cervical Dystonia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cervical Dystonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Cervical Dystonia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Cervical Dystonia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Cervical Dystonia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Cervical Dystonia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Cervical Dystonia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Cervical Dystonia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Cervical Dystonia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Cervical Dystonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Cervical Dystonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Cervical Dystonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Cervical Dystonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Cervical Dystonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Cervical Dystonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Cervical Dystonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Cervical Dystonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Cervical Dystonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Cervical Dystonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Cervical Dystonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Cervical Dystonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Cervical Dystonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Cervical Dystonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Cervical Dystonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Cervical Dystonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Cervical Dystonia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Cervical Dystonia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Cervical Dystonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Cervical Dystonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Cervical Dystonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Cervical Dystonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Cervical Dystonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Cervical Dystonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Cervical Dystonia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Allergan Company Details
Table 63. Allergan Business Overview
Table 64. Allergan Cervical Dystonia Therapeutics Product
Table 65. Allergan Revenue in Cervical Dystonia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Allergan Recent Development
Table 67. Eisai Company Details
Table 68. Eisai Business Overview
Table 69. Eisai Cervical Dystonia Therapeutics Product
Table 70. Eisai Revenue in Cervical Dystonia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Eisai Recent Development
Table 72. Ipsen Pharma Company Details
Table 73. Ipsen Pharma Business Overview
Table 74. Ipsen Pharma Cervical Dystonia Therapeutics Product
Table 75. Ipsen Pharma Revenue in Cervical Dystonia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Ipsen Pharma Recent Development
Table 77. Merz Pharma Company Details
Table 78. Merz Pharma Business Overview
Table 79. Merz Pharma Cervical Dystonia Therapeutics Product
Table 80. Merz Pharma Revenue in Cervical Dystonia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Merz Pharma Recent Development
Table 82. US WorldMeds Company Details
Table 83. US WorldMeds Business Overview
Table 84. US WorldMeds Cervical Dystonia Therapeutics Product
Table 85. US WorldMeds Revenue in Cervical Dystonia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. US WorldMeds Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cervical Dystonia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Botulinum Toxins Features
Figure 3. Drug Features
Figure 4. Other Features
Figure 5. Global Cervical Dystonia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Cervical Dystonia Therapeutics Report Years Considered
Figure 10. Global Cervical Dystonia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Cervical Dystonia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Cervical Dystonia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Cervical Dystonia Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Cervical Dystonia Therapeutics Market Share by Players in 2020
Figure 15. Global Top Cervical Dystonia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cervical Dystonia Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Cervical Dystonia Therapeutics Revenue in 2020
Figure 17. Global Cervical Dystonia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Cervical Dystonia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Cervical Dystonia Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Cervical Dystonia Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Cervical Dystonia Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cervical Dystonia Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Cervical Dystonia Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Cervical Dystonia Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cervical Dystonia Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Cervical Dystonia Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Cervical Dystonia Therapeutics Market Share by Region (2016-2027)
Figure 39. China Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cervical Dystonia Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Cervical Dystonia Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Cervical Dystonia Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cervical Dystonia Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Cervical Dystonia Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Cervical Dystonia Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Cervical Dystonia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Allergan Revenue Growth Rate in Cervical Dystonia Therapeutics Business (2016-2021)
Figure 59. Eisai Revenue Growth Rate in Cervical Dystonia Therapeutics Business (2016-2021)
Figure 60. Ipsen Pharma Revenue Growth Rate in Cervical Dystonia Therapeutics Business (2016-2021)
Figure 61. Merz Pharma Revenue Growth Rate in Cervical Dystonia Therapeutics Business (2016-2021)
Figure 62. US WorldMeds Revenue Growth Rate in Cervical Dystonia Therapeutics Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed


【掲載企業】

Allergan、Eisai、Ipsen Pharma、Merz Pharma、US WorldMeds

★調査レポート[世界の痙性斜頸治療市場規模・現状・予測2021-2027] (コード:QY21APR1251)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の痙性斜頸治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆